Investor Short Report Flags Steep Downside Risk For iRhythm Technologies - iRhythm Technologies ( NASDAQ:IRTC )
Spruce Point projects 40%-70% downside for iRhythm stock, or $43-$94 per share. iRhythm insiders sold $90 million-$160 million in stock during regulatory inaction. Get the exact trades and sectors to target before August's biggest earnings-driven market moves. Details here →
AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm's Zio LTCM Clinical Superiority
SAN FRANCISCO, Aug. 18, 2025 ( GLOBE NEWSWIRE ) -- iRhythm Technologies, Inc. ( NASDAQ:IRTC ) announced the publication of the real-world evidence study: Assessment of Variation in AmbuLatory Cardiac MONitoring: Real-World Evidence of Commercially Insured Beneficiaries ( AVALON ) in the American ...
AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm's Zio LTCM Clinical Superiority - iRhythm Technologies ( NASDAQ:IRTC )
In the largest real-world study of its kind with 428,707 patients, the Zio LTCM service outperformed other studied monitoring approaches in cardiac arrhythmia diagnostic yield, time to diagnosis, cardiovascular events, and total health care costs.
Tempus AI Stock Jumps Post Q2 as EBITDA Breakeven Nears: Buy or Hold?
Tempus AI's soaring Q2 revenues, margin gains and near-EBITDA breakeven position it as a fast-rising force in precision medicine.
iRhythm ( IRTC ) Q2 Revenue Jumps 26%
iRhythm Technologies ( NASDAQ:IRTC ) , a medical device company specializing in cardiac monitoring technology, reported its Q2 FY2025 results on July 31, 2025. The highlight was record revenue ( GAAP ) of $186.7 million, up 26.1% from the previous year and beating analyst expectations by $12.7 ...
Monolithic Power Systems, Workiva, Interface, AppFolio And Other Big Stocks Moving Higher On Friday - Rich Sparkle Holdings ( NASDAQ:ANPA ) , AppFolio ( NASDAQ:APPF )
U.S. stocks were lower, with the Dow Jones index falling around 500 points on Friday. Shares of Monolithic Power Systems, Inc. MPWR rose sharply during Friday's session after the company reported better-than-expected second-quarter financial results and issued third-quarter sales guidance above ...
iRhythm ( IRTC ) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.Thursday, July 31, 2025 at 4:30 p.m. ETPresident & CEO - Quentin S. BlackfordContinue reading ...
iRhythm Technologies ( IRTC ) Reports Q2 Loss, Tops Revenue Estimates
iRhythm Technologies (IRTC) delivered earnings and revenue surprises of +39.62% and +7.47%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions
iRhythm and Lucem Health partner to launch predictive AI for early arrhythmia detection in patients with comorbid conditions-enabling proactive heart care.
Hims & Hers Health, Inc. ( HIMS ) Reports Next Week: Wall Street Expects Earnings Growth
Hims & Hers Health (HIMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will iRhythm Technologies ( IRTC ) Report Negative Earnings Next Week? What You Should Know
iRhythm Technologies (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tempus AI Gains FDA Nod Amid Booming AI ECG Market Momentum
TEM secures FDA clearance for its AI-powered ECG tool targeting heart failure, as AI ECG adoption accelerates.
iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025 - iRhythm Technologies ( NASDAQ:IRTC )
SAN FRANCISCO, July 17, 2025 ( GLOBE NEWSWIRE ) -- iRhythm Technologies, Inc. IRTC, a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the second quarter 2025 after the ...
iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025
SAN FRANCISCO, July 17, 2025 ( GLOBE NEWSWIRE ) -- iRhythm Technologies, Inc. ( NASDAQ:IRTC ) , a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the second quarter ...
TEM Shares Surge on New AI Breakthrough: Should Investors Jump In?
TEM stock rallies 7.3% after the FDA clears its second cardiology AI tool, witnessing a 48% surge in just three months.
Integer Appoints Michael Coyle to Board of Directors - Integer Holdings ( NYSE:ITGR )
~ New Director Brings Extensive Medical Device Industry Leadership and Technology Experience to Integer Board ~
Integer Appoints Michael Coyle to Board of Directors
~ New Director Brings Extensive Medical Device Industry Leadership and Technology Experience to Integer Board ...
iRhythm Technologies Announces Board Member Retirements and New Director Appointments
SAN FRANCISCO, July 07, 2025 ( GLOBE NEWSWIRE ) -- iRhythm Technologies, Inc. ( NASDAQ:IRTC ) , a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the retirement of two long-serving board members, Mark Rubash and ...
iRhythm Technologies Announces Board Member Retirements and New Director Appointments - Absci ( NASDAQ:ABSI ) , Alphatec Holdings ( NASDAQ:ATEC )
SAN FRANCISCO, July 07, 2025 ( GLOBE NEWSWIRE ) -- iRhythm Technologies, Inc. IRTC , a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the retirement of two long-serving board members, Mark Rubash and Ralph ...
New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease - iRhythm Technologies ( NASDAQ:IRTC )
SAN FRANCISCO, June 23, 2025 ( GLOBE NEWSWIRE ) -- iRhythm Technologies, Inc. IRTC announced the results from two large-scale real-world studies presented at the American Diabetes Association's 85th Scientific Sessions ( ADA 2025 ) .
DOCS vs. IRTC: Who Will Win High-Stakes AI Showdown in Digital Health?
DOCS and IRTC are redefining digital health with AI, but only one is winning big with investors in 2025's market surge.
Robbins LLP Informs iRhythm Technologies, Inc. ( IRTC ) Investors That the Class Action Beat the Motion to Dismiss - iRhythm Technologies ( NASDAQ:IRTC )
SAN DIEGO, June 17, 2025 ( GLOBE NEWSWIRE ) -- A shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired iRhythm Technologies, Inc.
Innovation Fuels Rally for Tempus AI: Should You Buy the Stock Today?
Tempus AI surges 12.5% on new AI tools, a $200M AstraZeneca deal, and clinical data expansion- but is it time to buy?
iRhythm Technologies to Participate in Upcoming Investor Conferences - iRhythm Technologies ( NASDAQ:IRTC )
SAN FRANCISCO, May 21, 2025 ( GLOBE NEWSWIRE ) -- iRhythm Technologies, Inc. IRTC, a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that its management team is scheduled to present at the following investor ...
iRhythm Technologies to Participate in Upcoming Investor Conferences
SAN FRANCISCO, May 21, 2025 ( GLOBE NEWSWIRE ) -- iRhythm Technologies, Inc. ( NASDAQ:IRTC ) , a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that its management team is scheduled to present at the following ...
After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order?
President Donald Trump's new executive order aiming to cut U.S. drug prices could benefit Tempus AI.
Zio Demand Drives 20% Revenue Growth For iRhythm, Bullish Sentiment Builds Among Analysts - iRhythm Technologies ( NASDAQ:IRTC )
Q1 revenue rose 20.3% YoY to $158.7M, beating estimates; adjusted EPS loss narrowed to $0.95 vs. $1.23 last year. Gross margin improved to 68.8% from 66.3% YoY, driven by volume leverage and operational efficiencies in Zio services. Feel unsure about the market's next move?
This FTAI Aviation Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday - FTAI Aviation ( NASDAQ:FTAI ) , iRhythm Technologies ( NASDAQ:IRTC )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Stifel analyst Frank Galanti upgraded the rating for FTAI Aviation Ltd.
Trupanion Posts Better-Than-Expected Results, Joins Duolingo, DexCom, Exact Sciences And Other Big Stocks Moving Higher On Friday - Archer Aviation ( NYSE:ACHR ) , Adaptive Biotechnologies ( NASDAQ:ADPT )
U.S. stocks were higher, with the Dow Jones index gaining around 400 points on Friday. Shares of Trupanion, Inc. TRUP rose sharply during Friday's session after the company reported better-than-expected first-quarter financial results and raised its FY25 sales guidance.
IRhythm Technologies ( IRTC ) Reports Q1 Loss, Tops Revenue Estimates
iRhythm Technologies (IRTC) delivered earnings and revenue surprises of -6.74% and 3.34%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection - iRhythm Technologies ( NASDAQ:IRTC )
iRhythm Zio® Long-Term Continuous Monitoring ( LTCM ) system - commercially introduced in Japan as the Zio® ECG Recording and Analysis System - brings AI-powered, continuous, uninterrupted ECG monitoring for up to 14 days to Japan
iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference - iRhythm Technologies ( NASDAQ:IRTC )
SAN FRANCISCO, April 29, 2025 ( GLOBE NEWSWIRE ) -- iRhythm Technologies, Inc. IRTC, a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced the company will be participating in the upcoming Bank of America Securities ...
iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference
SAN FRANCISCO, April 29, 2025 ( GLOBE NEWSWIRE ) -- iRhythm Technologies, Inc. ( NASDAQ:IRTC ) , a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced the company will be participating in the upcoming Bank of ...
iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring
Data show iRhythm Zio LTCM clinical superiority with higher diagnostic yield, fewer retests, and fewer CV events vs. all other LTCMs products ...
iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring
• Findings in a younger, commercially insured population build on Medicare-based CAMELOT results, expanding the generalizability of Zio LTCM's clinical impact across patient groups. • Latest data showed Zio LTCM was associated with higher diagnostic yield and lower likelihood of repeat testing ...
The Zacks Analyst Blog Highlights Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS
Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS are included in this Analyst Blog.
Tempus AI Stock Sees 21% Gain in 3 Days: Is it a Buy After AZN Deal?
TEM stock rises for three successive days. Should you expect more upside ahead, or is it time to dump Tempus AI?
iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025 - iRhythm Technologies ( NASDAQ:IRTC )
SAN FRANCISCO, April 17, 2025 ( GLOBE NEWSWIRE ) -- iRhythm Technologies, Inc. IRTC, a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2025 after the ...
iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025
iRhythm Technologies to Report First Quarter 2025 Financial Results on May ...
iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability - iRhythm Technologies ( NASDAQ:IRTC )
SAN FRANCISCO, April 16, 2025 ( GLOBE NEWSWIRE ) -- iRhythm Technologies, Inc. IRTC, a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that it has published its 2024 Corporate Sustainability Report, highlighting ...
Tempus AI Surges 43% YTD: Is it the Right Time to Invest in the Stock?
The February 2025 acquisition of Ambry Genetics further expands TEM's genomics capabilities with a West Coast lab and enhanced inherited risk testing.
iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection
Two studies of over 1MM Zio LTCM patients reveal that short-term Holter monitoring frequently misses actionable arrhythmias ...
iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection
SAN FRANCISCO, March 31, 2025 ( GLOBE NEWSWIRE ) -- iRhythm Technologies, Inc. ( NASDAQ:IRTC ) today announced results from two large real-world retrospective analyses presented at the American College of Cardiology ( ACC ) 2025 Scientific Sessions in Chicago, IL. Drawing on data from more than ...
Tempus AI Surges 40% YTD: Are New Strategic Deals a Buy Signal?
The market's appetite for AI applications in healthcare is rapidly increasing, with TEM emerging as a top contender in this high-growth sector.
iRhythm Technologies ( IRTC ) Upgraded to Buy: Here's What You Should Know
iRhythm Technologies (IRTC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
DexCom CGM Sensor Sales to Continue Despite FDA Warning Letter
DXCM faces an FDA warning over manufacturing issues, but operations remain unaffected. However, supply-chain risks and rising competition pose challenges.
Tempus AI Falls 15% on Weak Q4 but EBITDA View Strong: Buy the Dip?
The acquisition of Ambry Genetics strengthens Tempus AI's genomics capabilities by adding a West Coast lab and expanding inherited risk testing.
IRhythm Technologies ( IRTC ) Beats Q4 Earnings and Revenue Estimates
iRhythm Technologies (IRTC) delivered earnings and revenue surprises of 103.33% and 4.19%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Will iRhythm Technologies ( IRTC ) Report Negative Earnings Next Week? What You Should Know
IRhythm Technologies (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inspire Medical Systems ( INSP ) Q4 Earnings and Revenues Surpass Estimates
Inspire (INSP) delivered earnings and revenue surprises of 55.41% and 0.04%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
